Summary
The final results of a randomised controlled study of xenon-arc photocoagulation for proliferative retinopathy are reported, after all patients have been followed for at least 5 years and some for up to 7 years. One hundred and seven patients with two similarly affected eyes had one treated (chosen by a random procedure), while the other eye remained untreated and served as a control. Of the 107 patients, 77 completed the 5 year follow up, 13 died and 17 stopped attending for various reasons. Of the recorded coexistent medical abnormalities, only renal complications affected survival, none influenced visual outcome. Visual outcome was significantly better in the treated than in the control eyes at each yearly interval (0.001<p<0.05). The greatest difference was seen in those with disc vessels at entry. In this group, control eyes deteriorated by a mean of four lines on the Snellen chart, treated eyes by one line only. Six patients became legally blind in both eyes, four were blind in the treated eye only, but 28 control eyes were blind when treated eyes retained vision (p<0.001). Treated eyes which became blind had less treatment than those that retained vision. Of the 42 treated eyes with peripheral new vessels only at entry, 12 developed disc new vessels. These 12 had fewer burns than the 30 which did not develop disc new vessels. It is concluded that in proliferative retinopathy, treatment by photocoagulation is better than no treatment at all. Adequate treatment is required to maintain vision.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Meyer-Schwickerath G (1979) Lichtkoagulation. Enke Verlag, Stuttgart
Diabetic Retinopathy Study Research Group (1976) Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 81: 383–397
British Multicentre Study Group (1977) Proliferative diabetic retinopathy; treatment with xenon arc photocoagulation. Br Med J 1: 739–742
Hercules BL, Gayed II, Lucas SB, Jaecock J (1977) Peripheral retinal ablation in the treatment of proliferative diabetic retinopathy. Br J Ophthalmol 61: 555–563
Diabetic Retinopathy Study Research Group (1981) Photocoagulation treatment of proliferative diabetic retinopathy. Diabetic Retinopathy Study, report No.8. Ophthalmology 88: 583–600
Oakley NW, Hill DW, Joplin GF, Kohner EM, Fraser TR (1967) Diabetic retinopathy I: assessment of severity and progression with a set of standard fundus photographs. Diabetologia 3: 402–405
Kohner EM, Panissett A, Cheng H, Fraser TR (1971) Diabetic retinopathy. New vessels arising from the optic disc I: grading system and natural history. Diabetes 20: 816–823
Armitage P (1971) Statistical methods in medical research. Black-well, Oxford, p 128
Asher R, Hunt S, Hamilton AM, Townsend C, Blach RK, Khoury D, Kohner EM, Morris DV (1981) Photocoagulation for optic disc new vessels in diabetic retinopathy. Int Ophthal 3: 79–85
Diabetic Retinopathy Study Research Group (1981) Design methods and baseline results. Invest Ophthalmol Vis Sci 21: 149–203
Aiello LM, Beetham WP, Baodimos MC, Chazan BI, Bradley RF (1969) Ruby laser photocoagulation in the treatment of proliferative diabetic retinopathy. In: Goldberg M, Fine S (eds) Treatment of diabetic retinopathy. United States Department of Public Health, pp 437–463
Deckert T, Simonson E, Poulsen JE (1967) Prognosis of proliferative retinopathy in juvenile diabetes. Diabetes 16: 728–737
Caird FI, Burditt AF, Draper GJ (1968) Diabetic retinopathy. A further study of prognosis for vision. Diabetes 17: 121–123
Davis MD, Hiller R, Magli YL, Podgor MJ, Ederer F, Harris WA, Long JW, Haug GA (1979) Prognosis for life in patients with diabetes in relation to severity of retinopathy. Trans Amer Ophth Soc 77: 144–170
Author information
Consortia
Rights and permissions
About this article
Cite this article
British Multicentre Study Group. Photocoagulation for proliferative diabetic retinopathy: a randomised controlled clinical trial using the xenon-arc. Diabetologia 26, 109–115 (1984). https://doi.org/10.1007/BF00281116
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00281116